Employee Shr Incent. Plan-Rep

Evolution Group PLC 05 August 2004 5 August 2004 Evolution Group Plc The following replaces the Employee Share Incentive Plan announcement released on 5 August at 12.30pm under RNS number 6696B. Sanne Trustee Company UK Limited purchased shares yesterday, and not today, as previously announced. All other details remain unchanged, and the full amended text appears below. Sanne Trustee Company UK Ltd as trustee of the Evolution Employee Share Incentive Plan Trust The Evolution Group Plc ("Evolution" or the "Company"), the investment bank and retail fund management group, announces that Sanne Trustee Company UK Limited (the "Trustee") in its capacity as the trustee of the Evolution Employee Share Incentive Plan (the "Plan") has yesterday purchased 7,286 Ordinary shares of 1p each at a price of 148 pence per share and that Evolution has today issued 6,615 Ordinary shares of 1p each credited as fully paid at 148 pence per share to the Trustee as "matching shares" under the terms of the Plan. The Trustee holds the shares as Nominee for the participants of the Plan. The purchase and issue included the following shares in respect of certain of its directors: Name of Number of Ordinary Total number of Interest of Percentage of Director shares (including Ordinary shares director in issued share matching and held by the Ordinary shares capital dividend shares) Trustee for including the represented acquired by the director shares held by the by director's Trustee for following such Trustee for the Total director acquisition director "Total Interest Interest") Alex Snow 170 2,854 431,956 0.17 Graeme Dell 170 2,854 50,674 0.02 Richard Griffiths 170 2,854 5,837,854 2.35 The above directors' interests exclude any interests in options over ordinary shares in the Company. ENDS For more information please contact: The Evolution Group Plc (www.evolution-group.com) Graeme Dell, Finance Director 020 7071 4300 This information is provided by RNS The company news service from the London Stock Exchange

Companies

Evgen Pharma (EVG)
UK 100

Latest directors dealings